HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease.

AuthorsAlberto J Espay, Robert A Hauser, Melissa J Armstrong
JournalJAMA neurology (JAMA Neurol) Vol. 77 Issue 3 Pg. 295-297 (03 01 2020) ISSN: 2168-6157 [Electronic] United States
PMID31841588 (Publication Type: Editorial, Comment)
Chemical References
  • Biomarkers
  • Pyrimidines
  • nilotinib
Topics
  • Biomarkers
  • Humans
  • Parkinson Disease (drug therapy)
  • Pyrimidines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: